|
شركة Quanterix Corporation (QTRX) DCF |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Quanterix Corporation (QTRX) Bundle
تقييم التوقعات المالية لشركة Quanterix Corporation كخبير! توفر حاسبة DCF (QTRX) هذه البيانات المالية المليئة مسبقًا جنبًا إلى جنب مع المرونة لتعديل نمو الإيرادات و WACC والهوامش وغيرها من الافتراضات الحرجة التي تتماشى مع توقعاتك.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 86.4 | 110.6 | 105.0 | 122.4 | 135.4 | 152.4 | 171.6 | 193.1 | 217.3 | 244.6 |
| Revenue Growth, % | 0 | 27.99 | -5.07 | 16.59 | 10.68 | 12.55 | 12.55 | 12.55 | 12.55 | 12.55 |
| EBITDA | -27.3 | -53.2 | -65.7 | -38.1 | -52.6 | -64.7 | -72.9 | -82.0 | -92.3 | -103.9 |
| EBITDA, % | -31.57 | -48.15 | -62.63 | -31.13 | -38.85 | -42.47 | -42.47 | -42.47 | -42.47 | -42.47 |
| Depreciation | 4.5 | 5.3 | 7.3 | 6.3 | .0 | 6.8 | 7.6 | 8.6 | 9.6 | 10.8 |
| Depreciation, % | 5.26 | 4.79 | 7 | 5.13 | 0 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 |
| EBIT | -31.8 | -58.5 | -73.1 | -44.4 | -52.6 | -71.5 | -80.5 | -90.6 | -101.9 | -114.7 |
| EBIT, % | -36.84 | -52.95 | -69.62 | -36.25 | -38.85 | -46.9 | -46.9 | -46.9 | -46.9 | -46.9 |
| Total Cash | 181.6 | 396.5 | 338.7 | 321.3 | 289.1 | 152.4 | 171.6 | 193.1 | 217.3 | 244.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 17.2 | 23.8 | 19.0 | 25.4 | 32.1 | 31.7 | 35.7 | 40.2 | 45.2 | 50.9 |
| Account Receivables, % | 19.89 | 21.51 | 18.12 | 20.77 | 23.73 | 20.81 | 20.81 | 20.81 | 20.81 | 20.81 |
| Inventories | 14.9 | 22.2 | 16.8 | 22.4 | 32.8 | 29.2 | 32.9 | 37.0 | 41.6 | 46.8 |
| Inventories, % | 17.2 | 20.07 | 15.99 | 18.28 | 24.2 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
| Accounts Payable | 6.8 | 9.2 | 3.8 | 5.0 | 7.0 | 8.9 | 10.0 | 11.2 | 12.7 | 14.2 |
| Accounts Payable, % | 7.87 | 8.33 | 3.66 | 4.13 | 5.13 | 5.82 | 5.82 | 5.82 | 5.82 | 5.82 |
| Capital Expenditure | -3.9 | -13.6 | -11.7 | -3.8 | -3.4 | -10.2 | -11.5 | -13.0 | -14.6 | -16.4 |
| Capital Expenditure, % | -4.55 | -12.32 | -11.17 | -3.1 | -2.49 | -6.72 | -6.72 | -6.72 | -6.72 | -6.72 |
| Tax Rate, % | -1.14 | -1.14 | -1.14 | -1.14 | -1.14 | -1.14 | -1.14 | -1.14 | -1.14 | -1.14 |
| EBITAT | -31.4 | -58.5 | -73.1 | -45.4 | -53.2 | -71.3 | -80.3 | -90.3 | -101.7 | -114.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -56.1 | -78.3 | -72.7 | -53.6 | -71.8 | -68.9 | -90.7 | -102.1 | -114.9 | -129.3 |
| WACC, % | 9.51 | 9.52 | 9.52 | 9.52 | 9.52 | 9.52 | 9.52 | 9.52 | 9.52 | 9.52 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -378.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -132 | |||||||||
| Terminal Value | -1,755 | |||||||||
| Present Terminal Value | -1,114 | |||||||||
| Enterprise Value | -1,493 | |||||||||
| Net Debt | -19 | |||||||||
| Equity Value | -1,473 | |||||||||
| Diluted Shares Outstanding, MM | 38 | |||||||||
| Equity Value Per Share | -38.40 |
What You Will Receive
- Comprehensive Financial Model: Quanterix Corporation’s (QTRX) actual data facilitates accurate DCF valuation.
- Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates provide immediate insights as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation purposes.
- Adaptable and Reusable: Designed for versatility, enabling repeated application for detailed projections.
Key Features
- Real-Time QTRX Data: Pre-loaded with Quanterix’s historical performance metrics and future growth estimates.
- Comprehensive Input Flexibility: Modify revenue projections, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Framework: Instant recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
- Multi-Scenario Analysis: Generate various forecasting scenarios to explore different valuation possibilities.
- Intuitive User Interface: Clean, organized design suitable for both industry experts and newcomers.
How It Works
- Step 1: Download the prebuilt Excel template featuring Quanterix Corporation’s (QTRX) data.
- Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly observe recalculated results, including Quanterix Corporation’s (QTRX) intrinsic value.
- Step 5: Make well-informed investment decisions or create reports based on the outputs.
Why Choose Quanterix Corporation (QTRX) Calculator?
- Precision: Utilizes real Quanterix financial data for unparalleled accuracy.
- Adaptability: Tailored for users to easily adjust and experiment with inputs.
- Efficiency: Eliminate the need to construct a financial model from the ground up.
- Expert-Level: Crafted with the precision and functionality expected by CFOs.
- Intuitive: Designed for simplicity, making it accessible to those with no advanced financial modeling skills.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing Quanterix Corporation (QTRX).
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the life sciences sector.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Quanterix Corporation (QTRX).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to biotech.
- Biotech Enthusiasts: Gain insights into how companies like Quanterix Corporation (QTRX) are valued in the investment landscape.
What the Template Contains
- Preloaded QTRX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.